Reward-aversion circuitry in analgesia and pain: Implications for psychiatric disorders

European Journal of Pain

Volumn 11, Issue 1, 2007, Pages 7-

  Borsook, David ^a   Becerra, Lino ^a   Carlezon Jr , William A ^b   Shaw, Marnie ^a   Renshaw, Perry ^a   Elman, Igor ^b   Levine, Jon ^c  

^a Brain Imaging Center   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anxiety; Depression; Functional illness; Functional imaging; Pain; Reward

Indexed keywords

AMFEBUTAMONE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CARBAMAZEPINE; CLONAZEPAM; DESIPRAMINE; DOXEPIN; DULOXETINE; FENTANYL; GABAPENTIN; IMIPRAMINE; LAMOTRIGINE; LEVODOPA; MORPHINE; NALOXONE; NORADRENALIN; OPIATE; PREGABALIN; REMIFENTANIL; SEROTONIN UPTAKE INHIBITOR; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT;

AMYGDALOID NUCLEUS; ANALGESIA; ANXIETY; ARTICLE; ATTENTION DISTURBANCE; AVERSION; BRAIN CORTEX; CENTRAL NERVOUS SYSTEM; CHRONIC PAIN; COGNITIVE DEFECT; COMORBIDITY; DEPRESSION; DRUG DEPENDENCE; EMOTIONALITY; FEAR; FUNCTIONAL DISEASE; HUMAN; HYPERALGESIA; MEMORY DISORDER; MENTAL DISEASE; NEUROBIOLOGY; NOCICEPTION; NONHUMAN; PHYSIOLOGY; PREFRONTAL CORTEX; PRIORITY JOURNAL; REWARD; SENSORY DYSFUNCTION; SENSORY STIMULATION; VENTRAL TEGMENTUM;

EID: 33751019472     PISSN: 10903801     EISSN: 15322149     Source Type: Journal    
DOI: 10.1016/j.ejpain.2005.12.005     Document Type: Article

References (194)

1. Abdolmaleky H.M., Thiagalingam S., and Wilcox M. Genetics and epigenetics in major psychiatric disorders: dilemmas, achievements, applications, and future scope. Am J Pharmacogenom 5 (2005) 149-160
2. Adler L.J., Gyulai F.E., Diehl D.J., Mintun M.A., Winter P.M., and Firestone L.L. Regional brain activity changes associated with fentanyl analgesia elucidated by positron emission tomography. Anesth Analg 84 (1997) 120-126 erratum appears in Anesth Analg 1997 May;84(5):949
3. Aharon I., Becerraa L., Chabris C.F., and Borsooka D. Noxious heat induces fMRI activation in two anatomically distinct clusters within the nucleus accumbens. Neurosci Lett 329 (2006) 159-164
4. Akbarian S., Rios M., Liu R.J., Gold S.J., Fong H.F., Zeiler S., et al. Brain-derived neurotrophic factor is essential for opiate-induced plasticity of noradrenergic neurons. J Neurosci 22 (2002) 4153-4162
5. Angst M.S., Koppert W., Pahl I., Clark D.J., and Schmelz M. Short-term infusion of the mu-opioid agonist remifentanil in humans causes hyperalgesia during withdrawal. Pain 106 (2003) 49-57
6. Apkarian A.V., Thomas P.S., Krauss B.R., and Szeverenyi N.M. Prefrontal cortical hyperactivity in patients with sympathetically mediated chronic pain. Neurosci Lett 311 (2001) 193-197
7. Apkarian A.V., Sosa Y., Krauss B.R., Thomas P.S., Fredrickson B.E., Levy R.E., et al. Chronic pain patients are impaired on an emotional decision-making task. Pain 108 (2004) 129-136
8. Apkarian A.V., Sosa Y., Sonty S., Levy R.M., Harden R.N., Parrish T.B., et al. Chronic back pain is associated with decreased prefrontal and thalamic gray matter density. J Neurosci 24 (2004) 104-105
9. Arnold L.M., Lu Y., Crofford L.J., Wohlreich M., Detke M.J., Iyengar S., et al. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheumat 50 (2004) 2974-2984
10. Baliki M., Al-Amin H.A., Atweh S.F., Jaber M., Hawwa N., Jabbur S.J., et al. Attenuation of neuropathic manifestations by local block of the activities of the ventrolateral orbito-frontal area in the rat. Neuroscience 120 (2003) 1093-1104
11. Bantick S.J., Wise R.G., Ploghaus A., Clare S., Smith S.M., and Tracey I. Imaging how attention modulates pain in humans using functional MRI. Brain. 125 Pt 2 (2002) 310-319
12. Barbaro N.M. Studies of PAG/PVG stimulation for pain relief in humans. Prog Brain Res 77 (1988) 165-173
13. Basbaum A.I., and Fields H.L. Endogenous pain control mechanisms: review and hypothesis. Ann Neurol 4 (1978) 451-462
14. Baxter M.G., and Murray E.A. The amygdala and reward. Nat Rev Neurosci 3 (2002) 563-573
15. Becerra L.R., Breiter H.C., Stojanovic M., Fishman S., Edwards A., Comite A.R., et al. Human brain activation under controlled thermal stimulation and habituation to noxious heat: an fMRI study. Magn Resonan Med 41 (1999) 1044-1057
16. Becerra L., Breiter H.C., Wise R., Gonzalez R.G., and Borsook D. Reward circuitry activation by noxious thermal stimuli. Neuron 32 (2001) 927-946
17. Becerra L, Gonzalez RG, Breiter HC, Borsook D, Activation in nucleus accumbens following pain and analgesia. In: Proceedings of the Society of Neuroscience, San Diego, CA, 2001b.
18. Becerra L., Iadarola M., and Borsook D. CNS activation by noxious heat to the hand or foot: site-dependent delay in sensory but not emotion circuitry. J Neurophysiol 91 (2004) 533-541
19. Bechara A. Risky business: emotion, decision-making, and addiction. J Gambl Stud 19 (2003) 23-51
20. Bechara A., Damasio H., Tranel D., and Anderson S.W. Dissociation of working memory from decision making within the human prefrontal cortex. J Neurosci 18 (1998) 428-437
21. Beitz A.J. The organization of afferent projections to the midbrain periaqueductal gray of the rat. Neuroscience 7 (1982) 133-159
22. Bernard J.F., Bester H., and Besson J.M. Involvement of the spino-parabrachio - amygdaloid and - hypothalamic pathways in the autonomic and affective emotional aspects of pain. Prog Brain Res 107 (1996) 243-255
23. Bernard J.F., Huang G.F., and Besson J.M. Nucleus centralis of the amygdala and the globus pallidus ventralis: electrophysiological evidence for an involvement in pain processes. J Neurophysiol 68 (1992) 551-569
24. Blackburn-Munro G. Hypothalamo-pituitary-adrenal axis dysfunction as a contributory factor to chronic pain and depression. Curr Pain Headache Rep 8 (2004) 116-124
25. Blackburn-Munro G., and Blackburn-Munro R.E. Chronic pain, chronic stress and depression: coincidence or consequence?. J Neuroendocrinol 13 (2001) 1009-1023
26. Blanchard R.J., and Fial R.A. Effects of limbic lesions on passive avoidance and reactivity to shock. J Comparat Physiol Psychol 66 (1968) 606-612
27. Bornhovd K., Quante M., Glauche V., Bromm B., Weiller C., and Buchel C. Painful stimuli evoke different stimulus-response functions in the amygdala, prefrontal, insula and somatosensory cortex: a single-trial fMRI study. Brain 125 (2002) 1326-1336
28. Borras M.C., Becerra L., Ploghaus A., Gostic J.M., DaSilva A., Gonzalez R.G., et al. fMRI measurement of CNS responses to naloxone infusion and subsequent mild noxious thermal stimuli in healthy volunteers. J Neurophysiol 91 (2004) 2723-2733
29. Breiter H.C., Gollub R.L., Weisskoff R.M., Kennedy D.N., Makris N., Berke J.D., et al. Acute effects of cocaine on human brain activity and emotion. Neuron 19 (1997) 591-611
30. Breslau N., Lipton R.B., Stewart W.F., Schultz L.R., and Welch K.M. Comorbidity of migraine and depression: investigating potential etiology and prognosis. Neurology 60 (2003) 1308-1312
31. Brown S.C., Glass J.M., and Park D.C. The relationship of pain and depression to cognitive function in rheumatoid arthritis patients. Pain 96 (2002) 279-284
32. Cabanac M. Physiological role of pleasure. Science 173 (1971) 1103-1107
33. Campbell L.C., Clauw D.J., and Keefe F.J. Persistent pain and depression: a biopsychosocial perspective. Biol Psychiatry 54 (2003) 399-409
34. Carrington Reid M., Williams C.S., Concato J., Tinetti M.E., and Gill T.M. Depressive symptoms as a risk factor for disabling back pain in community-dwelling older persons. J Am Geriatrics Soc 51 (2003) 1710-1717
35. Carroll L.J., Cassidy J.D., and Cote P. Depression as a risk factor for onset of an episode of troublesome neck and low back pain. Pain 107 (2004) 134-139
36. Casey K.L., Minoshima S., Berger K.L., Koeppe R.A., Morrow T.J., and Frey K.A. Positron emission tomographic analysis of cerebral structures activated specifically by repetitive noxious heat stimuli. J Neurophysiol 71 (1994) 802-807
37. Casey K.L., Lorenz J., and Minoshima S. Insights into the pathophysiology of neuropathic pain through functional brain imaging. Exp Neurol 184 Suppl. 1 (2003) S80-S88
38. Cohen R.A., Paul R., Zawacki T.M., Moser D.J., Sweet L., and Wilkinson H. Emotional and personality changes following cingulotomy. Emotion 1 (2001) 38-50
39. Comings D.E., and Blum K. Reward deficiency syndrome: genetic aspects of behavioral disorders. Prog Brain Res 126 (2000) 325-341
40. Compton P., Charuvastra V.C., and Ling W. Pain intolerance in opioid-maintained former opiate addicts: effect of long-acting maintenance agent. Drug Alcohol Depend 63 (2001) 139-146
41. Compton P., Athanasos P., and Elashoff D. Withdrawal hyperalgesia after acute opioid physical dependence in nonaddicted humans: a preliminary study. J Pain 4 (2003) 511-519
42. Condes-Lara M., Omana-Zapata I., and Talavera E. Facilitating action of medial prefrontal cortex upon the noxious thermally-evoked responses in thalamic centralis lateralis nucleus. J Physiol 85 (1991) 188-194
43. Corssen G., and Domino E.F. Dissociative anesthesia: further pharmacologic studies and first clinical experience with the phencyclidine derivative CI-581. Anesth Analg 45 (1966) 29-40
44. Croft P.R., Papageorgiou A.C., Ferry S., Thomas E., Jayson M.I., and Silman A.J. Psychologic distress and low back pain. Evidence from a prospective study in the general population. Spine 20 (1995) 2731-2737
45. Crombez G., Vlaeyen J.W., Heuts P.H., and Lysens R. Pain-related fear is more disabling than pain itself: evidence on the role of pain-related fear in chronic back pain disability. Pain 80 (1999) 329-339
46. Davis G.C., Buchsbaum M.S., and Bunney Jr. W.E. Analgesia to painful stimuli in affective illness. Am J Psychiatry 136 (1979) 1148-1151
47. Derbyshire S.W., Jones A.K., Gyulai F., Clark S., Townsend D., and Firestone L.L. Pain processing during three levels of noxious stimulation produces differential patterns of central activity. Pain. 73 (1997) 431-445
48. Derbyshire S.W., Jones A.K., Collins M., Feinmann C., and Harris M. Cerebral responses to pain in patients suffering acute post-dental extraction pain measured by positron emission tomography (PET). Eur J Pain 3 (1999) 103-113
49. Derbyshire S.W., Jones A.K., Creed F., Starz T., Meltzer C.C., Townsend D.W., et al. Cerebral responses to noxious thermal stimulation in chronic low back pain patients and normal controls. Neuroimage 16 (2002) 158-168
50. Derouesne C. Le concept d'apathie: interet et limites. Psychol Neuropsychiatrie Vieillisse 2 (2004) 19-28
51. Dill R.E., and Costa E. Behavioural dissociation of the enkephalinergic systems of nucleus accumbens and nucleus caudatus. Neuropharmacology 16 (1977) 323-326
52. Drevets W.C. Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression. Prog Brain Res 126 (2000) 413-431
53. Drevets W.C., Ongur D., and Price J.L. Neuroimaging abnormalities in the subgenual prefrontal cortex: implications for the pathophysiology of familial mood disorders. Mol Psychiatry 3 (1998) 220-226
54. Dworkin R.H. An overview of neuropathic pain: syndromes, symptoms, signs, and several mechanisms. Clin J Pain 18 (2002) 343-349
55. Dworkin R.H., Clark W.C., and Lipsitz J.D. Pain responsivity in major depression and bipolar disorder. Psychiatry Res 56 (1995) 173-181
56. Dworkin R.H., Backonja M., Rowbotham M.C., Allen R.R., Argoff C.R., Bennett G.J., et al. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. [see comment]. Arch Neurol 60 (2003) 1524-1534
57. Faillace L.A., Allen R.P., McQueen J.D., and Northrup B. Cognitive deficits from bilateral cingulotomy for intractable pain in man. Dis Nervous Syst 32 (1971) 171-175
58. Fava M., Mallinckrodt C.H., Detke M.J., Watkin J.G., and Wohlreich M.M. The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates?. J Clin Psychiatry 65 (2004) 521-530
59. Fields H.L. Pain modulation: expectation, opioid analgesia and virtual pain. Prog Brain Res 122 (2000) 245-253
60. Fields H. State-dependent opioid control of pain. Nat Rev Neurosci 5 (2004) 565-575
61. Finn D.P., Chapman V., Jhaveri M.D., Samanta S., Manders T., Bowden J., et al. The role of the central nucleus of the amygdala in nociception and aversion. Neuroreport 14 (2003) 981-984
62. Firestone L.L., Gyulai F., Mintun M., Adler L.J., Urso K., and Winter P.M. Human brain activity response to fentanyl imaged by positron emission tomography. Anesth Analg 82 (1996) 1247-1251
63. Flor H. The functional organization of the brain in chronic pain. Prog Brain Res 129 (2000) 313-322
64. Fraenkel Y.M., Kindler S., and Melmed R.N. Differences in cognitions during chest pain of patients with panic disorder and ischemic heart disease. Depress Anxiety 4 (1996) 217-222
65. Franklin K.B. Analgesia and the neural substrate of reward. Neurosci Biobehavior Rev 13 (1989) 149-154
66. Gear R.W., Aley K.O., and Levine J.D. Pain-induced analgesia mediated by mesolimbic reward circuits. J Neurosci 19 (1999) 7175-7181
67. Goldstein A. Heroin addiction: neurobiology, pharmacology, and policy. J Psychoactive Drugs 23 (1991) 123-133
68. Gottfried J.A., O'Doherty J., and Dolan R.J. Appetitive and aversive olfactory learning in humans studied using event-related functional magnetic resonance imaging. J Neurosci 22 (2002) 10829-10837
69. Gracely R.H., Geisser M.E., Giesecke T., Grant M.A., Petzke F., Williams D.A., et al. Pain catastrophizing and neural responses to pain among persons with fibromyalgia. Brain 127 (2004) 835-843
70. Gray J.A., and McNaughton N. The neuropsychology of anxiety (2000), Oxford University Press, Oxford
71. Gureje O., Simon G.E., and Von Korff M. A cross-national study of the course of persistent pain in primary care. Pain 92 (2001) 195-200
72. Hagelberg N., Martikainen I.K., Mansikka H., Hinkka S., Nagren K., Hietala J., et al. Dopamine D2 receptor binding in the human brain is associated with the response to painful stimulation and pain modulatory capacity. Pain 99 (2002) 273-279
73. Hagelberg N., Forssell H., Aalto S., Rinne J.O., Scheinin H., Taiminen T., et al. Altered dopamine D2 receptor binding in atypical facial pain. Pain 106 (2003) 43-48
74. Hagelberg N., Jaaskelainen S.K., Martikainen I.K., Mansikka H., Forssell H., Scheinin H., et al. Striatal dopamine D2 receptors in modulation of pain in humans: a review. Eur J Clin Pharmacol 500 (2004) 187-192
75. Haley W.E., Turner J.A., and Romano J.M. Depression in chronic pain patients: relation to pain, activity, and sex differences. Pain 23 (1985) 337-343
76. Hansson P.T., Fields H.F., Hill R.G., and Marchettini P. Neuropathic pain: pathophysiology and treatment progress pain research and management (2001), IASP Press, Seattle, WA
77. Hardy S.G. Analgesia elicited by prefrontal stimulation. Brain Res 339 (1985) 281-284
78. Hart R.P., Wade J.B., and Martelli M.F. Cognitive impairment in patients with chronic pain: the significance of stress. Curr Pain Headache Rep 7 (2003) 116-126
79. Horton J.E., Crawford H.J., Harrington G., and Downs III J.H. Increased anterior corpus callosum size associated positively with hypnotizability and the ability to control pain. Brain 127 (2004) 1741-1747
80. Hurt R.W., and Ballantine Jr. H.T. Stereotactic anterior cingulate lesions for persistent pain: a report on 68 cases. Clin Neurosurg 21 (1974) 334-351
81. Iezzi T., Archibald Y., Barnett P., Klinck A., and Duckworth M. Neurocognitive performance and emotional status in chronic pain patients. J Behavior Med 22 (1999) 205-216
82. Jenck F., Moreau J.L., and Martin J.R. Dorsal periaqueductal gray-induced aversion as a simulation of panic anxiety: elements of face and predictive validity. Psychiatry Res 57 (1995) 181-191
83. Jensen T.S., and Lenz F.A. Central post-stroke pain: a challenge for the scientist and the clinician. Pain 61 (1995) 161-164
84. Jensen J., McIntosh A.R., Crawley A.P., Mikulis D.J., Remington G., and Kapur S. Direct activation of the ventral striatum in anticipation of aversive stimuli. Neuron 40 (2003) 1251-1257
85. Jensen M.P., Nielson W.R., and Kerns R.D. Toward the development of a motivational model of pain self-management. J Pain 4 (2003) 477-492
86. Johansen J.P., and Fields H.L. Glutamatergic activation of anterior cingulate cortex produces an aversive teaching signal. Nat Neurosci 7 (2004) 398-403
87. Johansen J.P., Fields H.L., and Manning B.H. The affective component of pain in rodents: direct evidence for a contribution of the anterior cingulate cortex. Proc Natl Acad Sci USA 98 (2001) 8077-8082
88. Julius D., and Basbaum A.I. Molecular mechanisms of nociception. Nature 413 (2001) 203-210
89. Kayser V., Benoist J.M., and Guilbaud G. Low dose of morphine microinjected in the ventral periaqueductal gray matter of the rat depresses responses of nociceptive ventrobasal thalamic neurons. Neurosci Lett 37 (1983) 193-198
90. Keefe F.J., Rumble M.E., Scipio C.D., Giordano L.A., and Perri L.M. Psychological aspects of persistent pain: current state of the science. J Pain 5 (2004) 195-211
91. Kennedy R.M., and Luhmann J.D. The ouchless emergency department. Getting closer: advances in decreasing distress during painful procedures in the emergency department. Pediat Clin North Am 46 (1999) 1215-1247
92. King M.A., Bradshaw S., Chang A.H., Pintar J.E., and Pasternak G.W. Potentiation of opioid analgesia in dopamine2 receptor knock-out mice: evidence for a tonically active anti-opioid system. [see comment]. J Neurosci 21 (2001) 7788-7792
93. Knutson B., Adams C.M., Fong G.W., and Hommer D. Anticipation of increasing monetary reward selectively recruits nucleus accumbens. J Neurosci 21 (2001) RC159
94. Koob G.F., Ahmed S.H., Boutrel B., Chen S.A., Kenny P.J., Markou A., et al. Neurobiological mechanisms in the transition from drug use to drug dependence. Neurosci Biobehavior Rev 27 (2004) 739-749
95. Lautenbacher S., Spernal J., Schreiber W., and Krieg J.C. Relationship between clinical pain complaints and pain sensitivity in patients with depression and panic disorder. Psychosom Med 61 (1999) 822-827
96. LeDoux J. The emotional brain, fear, and the amygdala. Cell Mol Neurobiol 23 (2003) 727-738
97. Lenz F.A., Gracely R.H., Baker F.H., Richardson R.T., and Dougherty P.M. Reorganization of sensory modalities evoked by microstimulation in region of the thalamic principal sensory nucleus in patients with pain due to nervous system injury. J Comparat Neurol 399 (1998) 125-138
98. Levesque J., Eugene F., Joanette Y., Paquette V., Mensour B., Beaudoin G., et al. Neural circuitry underlying voluntary suppression of sadness. Biol Psychiatry 53 (2003) 502-510
99. Lorenz J., Minoshima S., and Casey K.L. Keeping pain out of mind: the role of the dorsolateral prefrontal cortex in pain modulation. Brain 126 (2003) 1079-1091
100. Lyness W.H., Friedle N.M., and Moore K.E. Destruction of dopaminergic nerve terminals in nucleus accumbens: effect on d-amphetamine self-administration. Pharmacol, Biochem Behav 11 (1979) 553-556
101. Maldonado R. The neurobiology of addiction. J Neural Transmiss (2003) 1-14 Supplementum
102. Maldonado R., Saiardi A., Valverde O., Samad T.A., Roques B.P., and Borrelli E. Absence of opiate rewarding effects in mice lacking dopamine D2 receptors. Nature 388 (1997) 586-589
103. Manning B.H. A lateralized deficit in morphine antinociception after unilateral inactivation of the central amygdala. J Neurosci 18 (1998) 9453-9470
104. Mansour A., Fox C.A., Burke S., Meng F., Thompson R.C., Akil H., et al. Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study. J Comparative Neurol 350 (1994) 412-438
105. Mansour A., Fox C.A., Akil H., and Watson S.J. Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci 18 (1995) 22-29
106. Mansour A., Watson S.J., and Akil H. Opioid receptors: past, present and future. Trends Neurosci 18 (1995) 69-70
107. Mansvelder H.D., Keath J.R., and McGehee D.S. Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas. Neuron 33 (2002) 905-919
108. Mantyh P.W. The ascending input to the midbrain periaqueductal gray of the primate. J Comparative Neurol 211 (1982) 50-64
109. Mao J. Opioid-induced abnormal pain sensitivity: implications in clinical opioid therapy. Pain 100 (2002) 213-217
110. Mao J., Mayer D.J., and Price D.D. Patterns of increased brain activity indicative of pain in a rat model of peripheral mononeuropathy. J Neurosci 13 (1993) 2689-2702
111. Max M.B., Kishore-Kumar R., Schafer S.C., Meister B., Gracely R.H., Smoller B., et al. Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial. Pain 45 (1991) 3-9 discussion 1-f-2
112. Max M.B., Lynch S.A., Muir J., Shoaf S.E., Smoller B., and Dubner R. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. [see comment]. New Engl J Med 326 (1992) 1250-1256
113. McBeth J., and Silman A.J. The role of psychiatric disorders in fibromyalgia. Curr Rheumatol Rep 3 (2001) 157-164
114. McCracken L.M., and Iverson G.L. Predicting complaints of impaired cognitive functioning in patients with chronic pain. J Pain Symptom Manage 21 (2001) 392-396
115. McCracken L.M., Faber S.D., and Janeck A.S. Pain-related anxiety predicts non-specific physical complaints in persons with chronic pain. Behav Res Therapy 36 (1998) 621-630
116. McEwen B.S. Plasticity of the hippocampus: adaptation to chronic stress and allostatic load. Ann New York Acad Sci 933 (2001) 265-277
117. McEwen B.S. Early life influences on life-long patterns of behavior and health. Mental Retardat Develop Disabil Res Rev 9 (2003) 149-154
118. McKenna J.E., and Melzack R. Analgesia produced by lidocaine microinjection into the dentate gyrus. Pain 49 (1992) 105-112
119. McNeil D.W., Au A.R., Zvolensky M.J., McKee D.R., Klineberg I.J., and Ho C.C. Fear of pain in orofacial pain patients. Pain 89 (2001) 245-252
120. Melzack R., and Casey K.L. Sensory, motivational, and central control determinants of pain. In: Kenshalo D.R. (Ed). The skin senses (1968), Thomas, Springfield, IL 423-439
121. Morgan M.J., and Franklin K.B. Stimulation-produced analgesia (SPA) from brain-stem and diencephalic sites in the rat: relationships between analgesia, aversion, seizures and catalepsy. Pain 33 (1988) 109-121
122. Nader K., Bechara A., and van der Kooy D. Neurobiological constraints on behavioral models of motivation. Ann Rev Psychol 48 (1997) 85-114
123. Naranjo C.A., Tremblay L.K., and Busto U.E. The role of the brain reward system in depression. Prog Neuro-Psychopharmacol Biol Psychiatry 25 (2001) 781-823
124. Narayanan S., Lam H., Christian L., Levine M.S., Grandy D., Rubinstein M., et al. Endogenous opioids mediate basal hedonic tone independent of dopamine D-1 or D-2 receptor activation. Neuroscience 124 (2004) 241-246
125. Neugebauer V., Li W., Bird G.C., and Han J.S. The amygdala and persistent pain. Neuroscientist 10 (2004) 221-234
126. Nieoullon A. Dopamine and the regulation of cognition and attention. Prog Neurobiol 67 (2002) 53-83
127. Noble E.P. Alcoholism and the dopaminergic system: a review. Addict Biol 1 (1996) 333-348
128. Nutt D.J., and Malizia A.L. Structural and functional brain changes in posttraumatic stress disorder. J Clin Psychiatry 65 Suppl. 1 (2004) 11-17
129. Olds M.E. Reinforcing effects of morphine in the nucleus accumbens. Brain Res 237 (1982) 429-440
130. Otis J.D., Keane T.M., and Kerns R.D. An examination of the relationship between chronic pain and post-traumatic stress disorder. J Rehabilitat Res Dev 40 (2003) 397-405
131. Ozaki S., Narita M., Iino M., Sugita J., Matsumura Y., and Suzuki T. Suppression of the morphine-induced rewarding effect in the rat with neuropathic pain: implication of the reduction in mu-opioid receptor functions in the ventral tegmental area. J Neurochem 82 (2002) 1192-1198
132. Paalzow G.H. l-dopa induces opposing effects on pain in intact rats: (-)-sulpiride, SCH 23390 or α-methyl-dl-p-tyrosine methylester hydrochloride reveals profound hyperalgesia in large antinociceptive doses. J Pharmacol Exp Therapeut 263 (1992) 470-479
133. Pande A.C., Crockatt J.G., Feltner D.E., Janney C.A., Smith W.T., Weisler R., et al. Pregabalin in generalized anxiety disorder: a placebo-controlled trial. Am J Psychiatry 160 (2003) 533-540
134. Paulson P.E., Casey K.L., and Morrow T.J. Long-term changes in behavior and regional cerebral blood flow associated with painful peripheral mononeuropathy in the rat. Pain 95 (2002) 31-40
135. Pay S., and Barasi S. A study of the connections of nociceptive substantia nigra neurones. Pain 12 (1982) 75-89
136. Petrovic P., Ingvar M., Stone-Elander S., Petersson K.M., and Hansson P. A PET activation study of dynamic mechanical allodynia in patients with mononeuropathy. Pain. 83 3 (1999) 459-470
137. Petrovic P., Kalso E., Petersson K.M., and Ingvar M. Placebo and opioid analgesia - imaging a shared neuronal network. Science 295 (2002) 1737-1740
138. Ploghaus A., Tracey I., Clare S., Gati J.S., Rawlins J.N., and Matthews P.M. Learning about pain: the neural substrate of the prediction error for aversive events. Proc Natl Acad Sci USA 97 (2000) 9281-9286
139. Ploghaus A., Narain C., Beckmann C.F., Clare S., Bantick S., Wise R., et al. Exacerbation of pain by anxiety is associated with activity in a hippocampal network. J Neurosci 21 (2001) 9896-9903
140. Ploghaus A., Becerra L., Borras C., and Borsook D. Neural circuitry underlying pain modulation: expectation, hypnosis, placebo. Trends Cognitive Sci 7 (2003) 197-200
141. Prado W.A., and Roberts M.H. An assessment of the antinociceptive and aversive effects of stimulating identified sites in the rat brain. Brain Res 340 (1985) 219-228
142. Price D.D. Psychological mechanisms of pain and analgesia. Progress in pain research and management (1999), IASP, Seattle, WA
143. Price D.D. Central neural mechanisms that interrelate sensory and affective dimensions of pain. Mol Intervent 2 (2002) 392-403
144. Rausell E., Cusick C.G., Taub E., and Jones E.G. Chronic deafferentation in monkeys differentially affects nociceptive and nonnociceptive pathways distinguished by specific calcium-binding proteins and down-regulates γ-aminobutyric acid type A receptors at thalamic levels. Proc Natl Acad Sci USA 89 (1992) 2571-2575
145. Reynolds D.V. Surgery in the rat during electrical analgesia induced by focal brain stimulation. Science 164 (1969) 444-445
146. Rhudy J.L., and Meagher M.W. Fear and anxiety: divergent effects on human pain thresholds. Pain 84 (2000) 65-75
147. Ridderinkhof K.R., Ullsperger M., Crone E.A., and Nieuwenhuis S. The role of the medial frontal cortex in cognitive control. Science 306 (2004) 443-447
148. Rogawski M.A., and Loscher W. The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions. Nat Med 10 (2004) 685-692
149. Rolls E.T. The brain and emotion (1999), Oxford University Press, New York
150. Rolls E.T. Memory systems in the brain. Ann Rev Psychol 51 (2000) 599-630
151. Rosenstock J., Tuchman M., LaMoreaux L., and Sharma U. Pregabalin for treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain 110 (2004) 628-638
152. Saade N.E., Atweh S.F., Bahuth N.B., and Jabbur S.J. Augmentation of nociceptive reflexes and chronic deafferentation pain by chemical lesions of either dopaminergic terminals or midbrain dopaminergic neurons. Brain Res 751 (1997) 1-12
153. Sage J.I. Pain in Parkinson's disease. Curr Treat Options Neurol 6 (2004) 191-200
154. Salomons T.V., Osterman J.E., Gagliese L., and Katz J. Pain flashbacks in posttraumatic stress disorder. Clin J Pain 20 (2004) 83-87
155. Sandkuhler J. The organization and function of endogenous antinociceptive systems. Prog Neurobiol 50 (1996) 49-81
156. Sante A.B., Nobre M.J., and Brandao M.L. Place aversion induced by blockade of mu or activation of kappa opioid receptors in the dorsal periaqueductal gray matter. Behaviour Pharmacol 11 (2000) 583-589
157. Sapolsky R.M. Stress and plasticity in the limbic system. Neurochem Res 28 (2003) 1735-1742
158. Schmidt B.L., Tambeli C.H., Barletta J., Luo L., Green P., Levine J.D., et al. Altered nucleus accumbens circuitry mediates pain-induced antinociception in morphine-tolerant rats. J Neurosci 22 (2002) 6773-6780
159. Schott G.D. Pain in Parkinson's disease. Pain 22 (1985) 407-411
160. Schultz W. Predictive reward signal of dopamine neurons. J Neurophysiol 80 (1998) 1-27
161. Schultz W. Neural coding of basic reward terms of animal learning theory, game theory, microeconomics and behavioural ecology. Curr Opin Neurobiol 14 (2004) 139-147
162. Sell L.A., Morris J., Bearn J., Frackowiak R.S., Friston K.J., and Dolan R.J. Activation of reward circuitry in human opiate addicts. Eur J Neurosci 11 (1999) 1042-1048
163. Sewards T.V., and Sewards M.A. Representations of motivational drives in mesial cortex, medial thalamus, hypothalamus and midbrain. Brain Res Bull 61 (2003) 25-49
164. Seymour B., O'Doherty J.P., Koltzenburg M., Wiech K., Frackowiak R., Friston K., and Dolan R. Opponent appetitive-aversive neural processes underlie predictive learning of pain relief. Nat Neurosci. 8 9 (2005) 1234-1240 Epub 2005 Aug 21
165. Shidara M., and Richmond B.J. Anterior cingulate: single neuronal signals related to degree of reward expectancy. [see comment]. Science 296 (2002) 1709-1711
166. Shizgal P. Neural basis of utility estimation. Curr Opin Neurobiol 7 (1997) 198-208
167. Sommer C. Painful neuropathies. Curr Opin Neurol 16 (2003) 623-628
168. Spinoza B. The collected works of Spinoza (1985), Princeton University Press, Princeton, NJ
169. Stewart C.A., and Reid I.C. Antidepressant mechanisms: functional and molecular correlates of excitatory amino acid neurotransmission. Mol Psychiatry 7 Suppl. 1 (2002) S15-S22
170. Strittmatter M., Bianchi O., Ostertag D., Grauer M., Paulus C., Fischer C., et al. Altered function of the hypothalamic-pituitary-adrenal axis in patients with acute, chronic, and episodic pain. Schmerz 19 (2005) 109-116
171. Suarez-Roca H., Pinerua-Shuhaibar L., Morales M.E., and Maixner W. Increased perception of post-ischemic paresthesias in depressed subjects. J Psychosom Res 55 (2003) 253-257
172. Svensson P., Minoshima S., Beydoun A., Morrow T.J., and Casey K.L. Cerebral processing of acute skin and muscle pain in humans. J Neurophysiol 78 (1997) 450-460
173. Tanimoto S., Nakagawa T., Yamauchi Y., Minami M., and Satoh M. Differential contributions of the basolateral and central nuclei of the amygdala in the negative affective component of chemical somatic and visceral pains in rats. Eur J Neurosci 18 (2003) 2343-2350
174. Tanji J., and Hoshi E. Behavioral planning in the prefrontal cortex. Curr Opin Neurobiol 11 (2001) 164-170
175. Tinazzi M., Fiaschi A., Rosso T., Faccioli F., Grosslercher J., and Aglioti S.M. Neuroplastic changes related to pain occur at multiple levels of the human somatosensory system: A somatosensory-evoked potentials study in patients with cervical radicular pain. J Neurosci 20 (2000) 9277-9283
176. Tzschentke T.M., and Schmidt W.J. Functional relationship among medial prefrontal cortex, nucleus accumbens, and ventral tegmental area in locomotion and reward. Crit Rev Neurobiol 14 (2000) 131-142
177. van Reekum R., Stuss D.T., and Ostrander L. Apathy: why care?. J Neuropsychiat Clin Neurosci 17 (2004) 7-19
178. Vollm B.A., De Araujo I.E., Cowen P.J., Rolls E.T., Kringelbach M.L., Smith K.A., et al. Methamphetamine activates reward circuitry in drug naive human subjects. Neuropsychopharmacology 29 (2004) 1715-1722
179. Wager T.D., Rilling J.K., Smith E.E., Sokolik A., Casey K.L., Davidson R.J., et al. Placebo-induced changes in FMRI in the anticipation and experience of pain. Science 303 (2004) 1162-1167
180. Wager T.D., Rilling J.K., Smith E.E., Sokolik A., Casey K.L., Davidson R.J., et al. Placebo-induced changes in FMRI in the anticipation and experience of pain. [see comment]. Science 303 (2004) 1162-1167
181. Wagner K.J., Willoch F., Kochs E.F., Siessmeier T., Tolle T.R., Schwaiger M., et al. Dose-dependent regional cerebral blood flow changes during remifentanil infusion in humans: a positron emission tomography study. Anesthesiology 94 (2001) 732-739
182. Walker D.L., Toufexis D.J., and Davis M. Role of the bed nucleus of the stria terminalis versus the amygdala in fear, stress, and anxiety. Eur J Pharmacol 463 (2003) 199-216
183. Weiss F., and Koob G.F. Drug addiction: functional neurotoxicity of the brain reward systems. Neurotox Res 3 (2001) 145-156
184. White F.J. Synaptic regulation of mesocorticolimbic dopamine neurons. Ann Rev Neurosci 19 (1996) 405-436
185. Wilkinson H.A., Davidson K.M., and Davidson R.I. Bilateral anterior cingulotomy for chronic noncancer pain. Neurosurgery 45 (1999) 1129-1134 discussion pp. 1134-1136
186. Wilson K.G., Eriksson M.Y., D'Eon J.L., Mikail S.F., and Emery P.C. Major depression and insomnia in chronic pain. Clin J Pain 18 (2002) 77-83
187. Wise R.A. Opiate reward: sites and substrates. Neurosci Biobehavior Rev 13 (1989) 129-133
188. Wise R.A. Addiction becomes a brain disease. Neuron 26 (2000) 27-33
189. Wise R.A. Brain reward circuitry: insights from unsensed incentives. Neuron 36 (2002) 229-240
190. Wise R.A. Dopamine, learning and motivation. Nat Rev Neurosci 5 (2004) 483-494
191. Wise R.A., and Hoffman D.C. Localization of drug reward mechanisms by intracranial injections. Synapse 10 (1992) 247-263
192. Woolf C.J., and Salter M.W. Neuronal plasticity: increasing the gain in pain. Science 288 (2000) 1765-1769
193. Zubieta J.K., Smith Y.R., Bueller J.A., Xu Y., Kilbourn M.R., Jewett D.M., et al. Regional mu opioid receptor regulation of sensory and affective dimensions of pain. Science 293 (2001) 311-315
194. Zubieta J.K., Bueller J.A., Jackson L.R., Scott D.J., Xu Y., Koeppe R.A., et al. Placebo effects mediated by endogenous opioid activity on mu-opioid receptors. J Neurosci 25 (2005) 7754-7762